Lupin

{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,415.00",
    "chg": -6.2,
    "chgp": "-0.26%",
    "dir": -1,
    "prev_price": "2,421.20",
    "mcapval": "110,742.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE326A01037",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "19:25 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "10.37 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-mixed-market-signals-4128902",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_oi_spurts_by_underlying_4128902.png",
        "date": "2026-07-30 15:00:11",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 16.55% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and closed 1.11% lower, reflecting a complex interplay between bullish bets and short-term profit-taking."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mid-Cap Pharma Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mid-cap-pharma-rally-4127871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_technicaldot_4127871.png",
        "date": "2026-07-30 08:01:35",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more assertive bullish trend. This transition is underscored by key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest strengthening price momentum. The stock’s recent performance, coupled with its mid-cap status and a Mojo Score of 77.0, positions it favourably against broader market benchmarks like the Sensex."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bullish-derivatives-activity-4126179",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_oi_spurts_by_underlying_4126179.png",
        "date": "2026-07-29 15:00:27",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a notable surge in open interest (OI) in its derivatives segment on 29 Jul 2026, signalling increased market participation and potential directional bets. The stock outperformed its sector peers and the broader Sensex, reflecting growing investor confidence amid evolving market dynamics."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Signalling Market Positioning Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-signalling-market-positioning-shift-4126129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_oi_spurts_by_underlying_4126129.png",
        "date": "2026-07-29 14:00:25",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector peers and the broader Sensex, supported by robust volume and price action, as investors recalibrate their positions amid evolving market dynamics."
      },
      {
        "title": "Lupin Ltd. Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-4125315",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_mojoScore_4125315.png",
        "date": "2026-07-29 08:24:52",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating adjusted from Strong Buy to Buy as of 28 July 2026. This recalibration reflects a nuanced shift in the company’s technical outlook despite robust financial performance and attractive valuation metrics. Investors are advised to consider the evolving technical signals alongside Lupin’s solid fundamentals when assessing the stock’s prospects."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4125079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_technicaldot_4125079.png",
        "date": "2026-07-29 08:02:19",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish trend. Despite a slight dip in the daily price, the stock’s technical indicators present a nuanced picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and their implications for investors."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-strong-market-returns-4123324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_technicaldot_4123324.png",
        "date": "2026-07-28 08:03:10",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading its outlook from mildly bullish to bullish. This change is underpinned by a confluence of positive signals from key technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor confidence and potential upside in the mid-cap stock."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Signalling Renewed Market Optimism",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-signalling-renewed-market-optimism-4122819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LupinLtd_oi_spurts_by_underlying_4122819.png",
        "date": "2026-07-27 15:00:28",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with a strong Mojo Score upgrade to 84.0 and a “Strong Buy” rating, underscores growing investor confidence amid a backdrop of improving fundamentals and sectoral tailwinds."
      },
      {
        "title": "Lupin Ltd. Falls 2.97%: 6 Key Factors Shaping This Week’s Market Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-falls-297-6-key-factors-shaping-this-weeks-market-moves-4120924",
        "imagepath": "",
        "date": "2026-07-26 09:01:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens strong at ₹2,478.30 (+1.48%) amid steady volume</p>\n                    <p><strong>21 Jul:</strong> Technical momentum shifts bullish; MarketsMOJO upgrades rating to Strong Buy</p>\n                    <p><strong>22 Jul:</strong> Bullish technical outlook confirmed with robust financials and valuation metrics</p>\n                    <p><strong>23 Jul:</strong> Significant open interest surge (+11.3%) amid price decline (-4.32%)</p>\n                    <p><strong>24 Jul:</strong> Continued open interest increase (+10.1%) with further price pressure (-1.11%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class..."
      }
    ],
    "total": 722,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "details": "Lupin Limited has informed the Exchange regarding Grant of 149578 Options.",
      "source": "NSE",
      "caption": "Lupin Limited - ESOP/ESOS/ESPS",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Lupin Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Lupin Foundation Wins Award for Excellence in Corporate Social Responsibility at India",
      "source": "NSE",
      "caption": "Lupin Limited - Press Release",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Lupin Limited has informed the Exchange regarding allotment of 60495 Equity Shares under ESOP",
      "source": "NSE",
      "caption": "Lupin Limited - Allotment of ESOP/ESPS",
      "datetime": "28-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "06 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>900%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lupin Ltd. Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-07-30 15:00:11

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 16.55% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and closed 1.11% lower, reflecting a complex interplay between bullish bets and short-term profit-taking.

Read full news article

Lupin Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mid-Cap Pharma Rally

2026-07-30 08:01:35

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more assertive bullish trend. This transition is underscored by key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest strengthening price momentum. The stock’s recent performance, coupled with its mid-cap status and a Mojo Score of 77.0, positions it favourably against broader market benchmarks like the Sensex.

Read full news article

Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Derivatives Activity

2026-07-29 15:00:27

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a notable surge in open interest (OI) in its derivatives segment on 29 Jul 2026, signalling increased market participation and potential directional bets. The stock outperformed its sector peers and the broader Sensex, reflecting growing investor confidence amid evolving market dynamics.

Read full news article

Lupin Ltd. Sees Significant Open Interest Surge Signalling Market Positioning Shift

2026-07-29 14:00:25

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector peers and the broader Sensex, supported by robust volume and price action, as investors recalibrate their positions amid evolving market dynamics.

Read full news article

Lupin Ltd. Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals

2026-07-29 08:24:52

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating adjusted from Strong Buy to Buy as of 28 July 2026. This recalibration reflects a nuanced shift in the company’s technical outlook despite robust financial performance and attractive valuation metrics. Investors are advised to consider the evolving technical signals alongside Lupin’s solid fundamentals when assessing the stock’s prospects.

Read full news article

Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-29 08:02:19

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish trend. Despite a slight dip in the daily price, the stock’s technical indicators present a nuanced picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and their implications for investors.

Read full news article

Lupin Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Strong Market Returns

2026-07-28 08:03:10

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading its outlook from mildly bullish to bullish. This change is underpinned by a confluence of positive signals from key technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor confidence and potential upside in the mid-cap stock.

Read full news article

Lupin Ltd. Sees Significant Open Interest Surge Signalling Renewed Market Optimism

2026-07-27 15:00:28

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with a strong Mojo Score upgrade to 84.0 and a “Strong Buy” rating, underscores growing investor confidence amid a backdrop of improving fundamentals and sectoral tailwinds.

Read full news article

Lupin Ltd. Falls 2.97%: 6 Key Factors Shaping This Week’s Market Moves

2026-07-26 09:01:50

Key Events This Week

20 Jul: Stock opens strong at ₹2,478.30 (+1.48%) amid steady volume

21 Jul: Technical momentum shifts bullish; MarketsMOJO upgrades rating to Strong Buy

22 Jul: Bullish technical outlook confirmed with robust financials and valuation metrics

23 Jul: Significant open interest surge (+11.3%) amid price decline (-4.32%)

24 Jul: Continued open interest increase (+10.1%) with further price pressure (-1.11%)

Read full news article

View All News